Best Practice: Developing Drugs that are Highly PotentByColin MacKayApril 22nd 2016Highly potent or cytotoxic drugs require special handling
Gauging Change in Europe’s Sterile Manufacturing MarketByColin MacKayApril 22nd 2015The past six months has seen some major changes to the sterile manufacturing landscape in Europe. There have been a number of exits and acquisitions that have no doubt grabbed headlines, but has anything really changed?